Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Profile and variables related to antipsychotic consumption according to dementia subtypes.

Calvó-Perxas L, de Eugenio RM, Marquez-Daniel F, Martínez R, Serena J, Turbau J, Vilalta-Franch J, Viñas M, Turró-Garriga O, Roig AM, López-Pousa S, Garre-Olmo J; Registry of Dementias of Girona Study.

Int Psychogeriatr. 2012 Jun;24(6):940-7. doi: 10.1017/S1041610212000026. Epub 2012 Feb 14.

PMID:
22333005
2.

Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain).

Avila-Castells P, Garre-Olmo J, Calvó-Perxas L, Turró-Garriga O, Alsina E, Carmona O, Perkal H, Roig AM, Cuy JM, Lozano M, Molins A, Vallmajó N, López-Pousa S; Registry Dementia of Girona Study Group.

Eur J Clin Pharmacol. 2013 May;69(5):1047-56. doi: 10.1007/s00228-012-1451-y. Epub 2012 Nov 23. Review.

PMID:
23179177
3.

Psychotropic drugs in patients with Alzheimer's Disease: a longitudinal study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain.

Calvó-Perxas L, Turró-Garriga O, Aguirregomozcorta M, Bisbe J, Hernández E, López-Pousa S, Manzano A, Palacios M, Pericot-Nierga I, Perkal H, Ramió L, Vilalta-Franch J, Garre-Olmo J; Registry of Dementias of Girona Study Group (ReDeGi Study Group).

J Am Med Dir Assoc. 2014 Jul;15(7):497-503. doi: 10.1016/j.jamda.2014.02.003. Epub 2014 Mar 14.

PMID:
24637090
4.

Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients.

Johnell K, Religa D, Eriksdotter M.

Dement Geriatr Cogn Disord. 2013;35(5-6):239-48. doi: 10.1159/000348408. Epub 2013 Mar 7.

PMID:
23485654
5.

Prescribing pattern of psychotropic drugs in nursing home residents with dementia.

Wetzels RB, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT.

Int Psychogeriatr. 2011 Oct;23(8):1249-59. doi: 10.1017/S1041610211000755. Epub 2011 Jun 20.

PMID:
21682938
6.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

7.

Antipsychotic prescriptions in a university hospital outpatient population in Turkey: a retrospective database analysis, 2005-2006.

Atik L, Erdogan A, Karaahmet E, Saracli O, Atasoy N, Kurcer MA, Balcioglu I.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):968-74. doi: 10.1016/j.pnpbp.2007.12.031. Epub 2008 Jan 11.

PMID:
18243462
8.

Behavioral and psychologic symptoms in different types of dementia.

Chiu MJ, Chen TF, Yip PK, Hua MS, Tang LY.

J Formos Med Assoc. 2006 Jul;105(7):556-62.

9.

Gender differences in clinical manifestations and outcomes among hospitalized patients with behavioral and psychological symptoms of dementia.

Kitamura T, Kitamura M, Hino S, Tanaka N, Kurata K.

J Clin Psychiatry. 2012 Dec;73(12):1548-54. doi: 10.4088/JCP.11m07614.

PMID:
23290328
10.

Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.

Haw C, Stubbs J, Yorston G.

Int Psychogeriatr. 2008 Aug;20(4):790-9. doi: 10.1017/S1041610208006819. Epub 2008 Feb 29.

PMID:
18307825
11.

Consumption of pharmaceuticals in primary non-Alzheimer's degenerative dementias : a cross-sectional study by the Registry of Dementias of Girona (ReDeGi).

López-Pousa S, Turró-Garriga O, Calvó-Perxas L, Carmona O, Gich J, Alsina E, Màrquez F, Viñas M, Turbau J, Vilalta-Franch J, Roig AM, Garre-Olmo J.

Drugs Aging. 2012 Sep;29(9):733-40.

PMID:
23018609
12.

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.

Barnes TR, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C.

Br J Psychiatry. 2012 Sep;201(3):221-6. doi: 10.1192/bjp.bp.111.107631. Epub 2012 Jul 12.

13.

Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.

Frisoni GB, Canu E, Geroldi C, Brignoli B, Anglani L, Galluzzi S, Zacchi V, Zanetti O.

Aging Clin Exp Res. 2007 Oct;19(5):349-55.

PMID:
18007112
14.

A long-term care center interdisciplinary education program for antipsychotic use in dementia: program update five years later.

Vida S, Monette J, Wilchesky M, Monette M, Friedman R, Nguyen A, Dastoor D, Cristache G, Sourial N, Tremblay L, Gore B.

Int Psychogeriatr. 2012 Apr;24(4):599-605. doi: 10.1017/S1041610211002225. Epub 2011 Nov 30.

PMID:
22126992
15.

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG.

J Clin Psychiatry. 2005 May;66(5):633-7.

PMID:
15889951
16.

[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].

Drach LM.

Med Monatsschr Pharm. 2011 Feb;34(2):47-52; quiz 53-4. Review. German.

PMID:
21428015
17.

[Clinical and demographic characteristics of the cases of dementia diagnosed in the Health District of Girona throughout the period 2007-2010: data from the Girona Dementia Registry (ReDeGi)].

Calvo-Perxas L, Osuna MT, Gich J, Eligio-Hernandez E, Linares M, Vinas M, Casas I, Turro-Garriga O, Lopez-Pousa S, Garre-Olmo J; En Representación Del Grupo de Estudio Del Registro de Demencias de Girona.

Rev Neurol. 2012 Apr 1;54(7):399-406. Spanish.

18.

Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.

Perri R, Monaco M, Fadda L, Caltagirone C, Carlesimo GA.

J Alzheimers Dis. 2014;39(3):669-77. doi: 10.3233/JAD-131337.

PMID:
24254701
19.

Neuropsychiatric and parkinsonian manifestations of dementia: a case report in a Nigerian woman.

Adebayo PB, Ajani AA, Adeniji OA, Akinyemi RO.

Ann Afr Med. 2013 Jan-Mar;12(1):46-8. doi: 10.4103/1596-3519.108252.

20.

Antipsychotic use in children and adolescents: a 1-year follow-up study.

Baeza I, de la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C, Castro-Fornieles J.

J Clin Psychopharmacol. 2014 Oct;34(5):613-9. doi: 10.1097/JCP.0000000000000190.

PMID:
25154009

Supplemental Content

Support Center